Szabo et al. reported that treatment of nude mice with a CBS inhibitor could attenuate the growth of patient-derived colon cancer xenografts and reduce peritumoral blood flow (Szabo et al., 2013). The gene discussed is CBS; the disease is colonic neoplasm.